financetom
Business
financetom
/
Business
/
Science Applications International's Fiscal Q4 Adjusted Earnings, Revenue Decline; Raises Fiscal 2025 Revenue Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Science Applications International's Fiscal Q4 Adjusted Earnings, Revenue Decline; Raises Fiscal 2025 Revenue Guidance
Mar 18, 2024 5:06 AM

07:47 AM EDT, 03/18/2024 (MT Newswires) -- Science Applications International ( SAIC ) reported fiscal Q4 adjusted earnings Monday of $1.43 per diluted share, compared with $2.04 a year earlier.

Analysts surveyed by Capital IQ expected $1.44.

Revenue for the quarter ended Feb. 2 was $1.74 billion, compared with $1.97 billion a year earlier.

Analysts surveyed by Capital IQ expected $1.64 billion.

For full-year fiscal 2025, the company maintained its guidance of adjusted earnings of $8.00 to $8.20 per diluted share, and raised its revenue outlook to a range of $7.35 billion to $7.50 billion from previous guidance of $7.25 billion to $7.40 billion. Analysts polled by Capital IQ expect adjusted earnings of $8.12 on revenue of $7.34 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Apple Reportedly Shuts Down Buy-Now-Pay-Later Service
Apple Reportedly Shuts Down Buy-Now-Pay-Later Service
Jun 17, 2024
05:57 PM EDT, 06/17/2024 (MT Newswires) -- Apple ( AAPL ) has discontinued its buy-now-pay-later service Apple Pay Later, media outlets reported Monday, citing a company statement. The company is reportedly shifting its focus to new global features for Apple Pay, including installment loans via eligible credit or debit cards, and partners like Affirm (AFRM). Users with ongoing Apple Pay...
Recursion Pharmaceuticals Insider Sold Shares Worth $278,880, According to a Recent SEC Filing
Recursion Pharmaceuticals Insider Sold Shares Worth $278,880, According to a Recent SEC Filing
Jun 17, 2024
05:53 PM EDT, 06/17/2024 (MT Newswires) -- Michael Secora, Chief Financial Officer, on June 13, 2024, sold 30,000 shares in Recursion Pharmaceuticals ( RXRX ) for $278,880. Following the Form 4 filing with the SEC, Secora has control over a total of 1,267,843 shares of the company, with 1,267,843 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1601830/000160183024000083/xslF345X03/wk-form4_1718660802.xml Price: 9.36, Change: -0.01, Percent...
Global Net Lease Insider Sold Shares Worth $3,652,821, According to a Recent SEC Filing
Global Net Lease Insider Sold Shares Worth $3,652,821, According to a Recent SEC Filing
Jun 17, 2024
05:51 PM EDT, 06/17/2024 (MT Newswires) -- Nicholas S Schorsch, 10% Owner, on June 13, 2024, sold 504,778 shares in Global Net Lease ( GNL ) for $3,652,821. Following the Form 4 filing with the SEC, Schorsch has control over a total of 30,760,633 shares of the company, with 409,945 shares held directly and 30,350,688 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1526113/000095014224001644/xslF345X03/es240497120_4-gnlschorsch.xml...
Transunion Insider Sold Shares Worth $511,700, According to a Recent SEC Filing
Transunion Insider Sold Shares Worth $511,700, According to a Recent SEC Filing
Jun 17, 2024
06:00 PM EDT, 06/17/2024 (MT Newswires) -- Heather J Russell, Executive Vice President, Chief Legal Officer, on June 14, 2024, sold 7,000 shares in Transunion ( TRU ) for $511,700. Following the Form 4 filing with the SEC, Russell has control over a total of 32,744 shares of the company, with 32,744 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1552033/000174175024000007/xslF345X03/wk-form4_1718661331.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved